MedTrace Logo

Correlation of Blood Gene Expression (TruGraf Liver) With Liver Biopsy in Pediatric Liver Transplant Recipients

NCT06263114 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2025-02-18

No results posted yet for this study

Summary

Liver transplant rejection is when the body's immune system attacks and damages the liver of a transplant recipient. Currently the best way to see if that is happening is with a liver biopsy. The purpose of this research study is to see if a simple blood test can diagnose if a transplanted liver is being rejected.

Conditions

  • Liver Transplant; Complications
  • Liver Failure, Acute

Interventions

DIAGNOSTIC_TEST

TruGraf® Liver gene expression panel (GEP)

Test done on blood sample collected during for cause or routine liver biopsy

Sponsors & Collaborators

  • Eurofins

    collaborator INDUSTRY

  • Children's Mercy Hospital Kansas City

    lead OTHER

Principal Investigators

  • Ryan Fischer, MD · Children's Mercy Hospital Kansas City

Eligibility

Min Age
1 Year
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-02-07
Completion
2025-02-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06263114 on ClinicalTrials.gov